课题基金 / 基金详情

AUTOMATED ID OF PROTEINS, VARIANTS & POST-TRANSLATIONAL MODIFICATIONS

AUTOMATED ID OF PROTEINS, VARIANTS & POST-TRANSLATIONAL MODIFICATIONS
蛋白质、变体的自动识别
批准号:
7369203
负责人:
DAVID H K CHUI
金额:
$0.17万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30

项目摘要

项目成果

DAVID H K CHUI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. More than 1200 recognized hemoglobin (Hb) structural variants exist in the human population, many of which may clinically manifest themselves as a disease state. Additionally, post-translational modifications (PTMs) of Hb that are not observed in gene-based analysis may play an important role in this disease. A reliable LC-MS/MS technique coupled with a proteomics based data analysis approach is needed to fully identify HB variants and their PTMs. In this study, a robust and reliable LC-MS/MS proteomics based method for automated characterization of Hb protein variants and PTMs is being explored. Whole blood is washed with PBS, diluted and frozen prior to use. Proteins are separated and digested with trypsin and the digests are analyzed by online LC-MS/MS (QTOF-API-US, Waters Corporation). Accurate mass is calculated in real time by operation of a reference Lockspray. Data are processed using ProteinLynx Global Server 2.05 (Waters) and searched against SwissProt and custom programmed Hemoglobin/PTM databases. In our method, as minimal purification, derivatization or separation is required, the sample preparation is considerably simplified. Full automation of data analysis methodology has been established by which the biases and skill of an operator do not limit the success of the identification process. Data analysis time is reduced by using a pre-programmed Hb database search in which Hb-derived tryptic peptides (including variants and modifications) are unambiguously identified, while the peptides not derived from Hb can be digitally filtered out, based on the accuracies of mass measurement of the high resolution QTOF instrument. Various PTMs have also been programmed for automatic PTM search. This simplified sample preparation procedure and the automated data analysis are critical components of this proteomic approach in enabling high through-put sample analysis/data interpretation and ensure precise and accurate data consistency. Samples of Hb that cannot be analyzed by the standard CE-based protocols of the BUSM Sickle Cell laboratory are now frequently analyzed by LC/MS and MS/MS. LC-MS/MS allows the detection of variants, provides a rapid alternative to DNA analysis with additional information obtained for PTMs and has potential for clinical use. (A separately-described Core Research project is exploring the development of even more advanced approaches to this analytical challenge.)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
  • 批准号:
    8294700
  • 项目类别:
  • 资助金额:
    $121.89万
  • 财政年份:
    2011
  • 负责人:
    DAVID H K CHUI
  • 依托单位:
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
  • 批准号:
    8094700
  • 项目类别:
  • 资助金额:
    $79.8万
  • 财政年份:
    2011
  • 负责人:
    DAVID H K CHUI
  • 依托单位:
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
  • 批准号:
    8501667
  • 项目类别:
  • 资助金额:
    $220.01万
  • 财政年份:
    2011
  • 负责人:
    DAVID H K CHUI
  • 依托单位:
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
  • 批准号:
    8691997
  • 项目类别:
  • 资助金额:
    $223.13万
  • 财政年份:
    2011
  • 负责人:
    DAVID H K CHUI
  • 依托单位:
国内基金
海外基金
ID2驱动的生物钟紊乱通过PI3K-AKT信号轴调控前列腺癌细胞异质性和可塑性的研究
  • 批准号:
    JCZRLH202600193
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Id2在胶质母细胞瘤中的作用及Id2/Oligo2促进胶质母细胞瘤EMT的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭灿
  • 依托单位:
清肺合剂上调丁酸调控 HDACs/ID2/IL-12R 通 路增强 PD-1 抑制剂抗肺癌作用的机制研究
  • 批准号:
    Q24H290030
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈卓
  • 依托单位:
DRAL-Id3 轴在造血应激状态下调控 HSCs 自 我更新的分子机制研究
  • 批准号:
    Y24H080015
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈一瑞
  • 依托单位: